India Approves First Dengue Vaccine, Qdenga
India has approved its first dengue vaccine, Qdenga by Takeda, for individuals aged 4 to 60, following clearance from the DCGI. This marks a significant step in the country's efforts to combat dengue fever.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)Sources
India approves its first dengue vaccine QDENGA after DCGI clearance
Dengue is a mosquito-borne viral disease reported in more than 125 countries. According to the company, India accounts for nearly one-third of the global dengue burden, with rapid urbanisation, climate change and widespread mosquito breeding continuing to increase the risk of infection across the country. Vaccine QDENGA is given as two injections of 0.5 ml, administered under the skin three months apart.
By TOI NEWS DESK
Read full article →India’s first dengue vaccine approved: DCGI clears Takeda’s Qdenga for those aged 4 to 60
By Anuradha Mascarenhas
Read full article →Coverage Timeline
Related Stories

Iran and Oman Agree on Strait of Hormuz Shipping Route Amid Tensions
24m ago

S. Korean response team continues search efforts for 9 missing in Nepal floods
29m ago

Deadly Flash Floods Leave Nearly 2,500 Missing Across Nepal
1h ago

Devastating Flash Floods Along Nepal-China Border Leave Thousands Missing
1h ago